Ornipressin (omithine-8-vasopressin, POR-8) is the most commonly used vasopressin analogue in Germany, Switzerland, New Zealand and Australia. While it has minimal antidiuretic activity whilst maintaining equipotent vasoconstrictor activity as the natural hormone, vasoprssin.
CAT# | 10-101-40 |
CAS | 3397-23-7 |
Background | Ornipressin is a potent vasoconstrictor agent, and plasma volume expansion with albumin to improve effective arterial blood volume. In vitro: Ornipressin produces a profound vasoconstrictive effect by contracting smooth-muscle cells in the vascular bed, especially in capillaries, small arterioles and venules. Ornipressin is most commonly used to treat bleeding oesophageal varices. >> Read More |
Synonyms/Alias | Ornithine Vasopressin; Ornithine-8-Vasopressin; Orpressin; POR-8; Ornipressina; Ornipressin; Ornipresina; POR8; POR 8 |
M.F/Formula | C45H63N13O12S2 |
M.W/Mr. | 1042.19 |
Sequence | Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Orn-Gly-NH2(Cys1-Cys6) |
Labeling Target | Gonadotropin-releasing hormone (GNRH) Receptor |
Application | Ornipressin is a vasoconstrictor, haemostatic and renal agent. |
Appearance | Solid powder |
Purity | >98% (or refer to the Certificate of Analysis) |
Biological Activity | Ornipressin is a potent vasoconstrictor, hemostatic and renal agent. |
Areas of Interest | Cardiovascular System & Diseases Pituitary & Hypothalamic Hormones |
Functions | Peptide binding |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Foreword We live in a photoshopped world, where we are constantly updated by images of digital perfection. It's easy to becom ...
What is palmitoyl hexapeptide-12? Lipopeptides, also known as acylpeptides, consist of a hydrophilic peptide bond and a lipo ...
The 70-kDa heat shock protein (HSP70) contains three domains: the ATPase N-domain, which hydrolyses ATP, the sub ...
KAI-1455, a ε-protein kinase C activator in Phase I testing for the treatment of ischemia-induced reperfusion i ...
KAI-1678, a synthetic 21-amino acid, is a novel PKC-epsilon (ε-PKC) inhibitor with a molecular weight of 2541 Da ...